在阿片类药物使用障碍的个体中使用二:叙述性审查
Yue Liu1,2, Qingxiao Hong2, Xiaohu Xie2
1Department of Psychiatry, Affiliated Kangning Hospital of Ningbo University, Ningbo, Zhejiang, 315201, People's Republic of China.
Substance abuse and rehabilitation
|October 27, 2025
概括
bensodiazepine (BZD) 的共同使用在阿片类药物使用障碍 (OUD) 中很常见,并预测过量死亡. 患者教育,治疗和传统中医等干预措施可以减轻伤害并改善OUD治疗结果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
- 成 药物 药物 药物 药物
背景情况:
- 在患有阿片类药物使用障碍 (OUD) 的个体中,同时使用二西平 (BZD) 非常普遍.
- 这种共同使用正在迅速增加,是阿片类药物过量死亡的重要预测因素.
- 滥用BZD与抑郁症,认知障碍和意外风险增加有关.
研究的目的:
- 为了突出与类药物共用在阿片类药物使用障碍中相关的风险.
- 强调临床警和及时干预的必要性.
- 探索潜在的替代治疗方法来管理与BZD相关的症状.
主要方法:
- 审查现有的关于二和阿片类药物使用障碍的文献.
- 对BZD和阿片类药物联合使用对过量使用风险和患者结局的影响的分析.
- 对焦虑,失眠和戒断症状的非成管理策略的探索.
主要成果:
- bensodiazepine 的共同使用是致命的阿片类药物过量服用的主要风险因素.
- 长期使用BZD会导致耐受性,依赖性和不良健康影响.
- 传统中医 (TCM) 显示出作为管理BZD相关症状的替代方案的希望.
结论:
- 门诊医生必须对同时使用BZD进行查,并在处方时保持谨慎.
- 包括教育,逐步停止和治疗在内的干预措施对于降低危害至关重要.
- 需要多方面的策略,可能包括TCM,以减少OUD患者使用BZD的负担.
更多相关视频
相关概念视频
CNS Depressants: Barbiturates and Benzodiazepines
1.1K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.1K
Sedatives and Hypnotics Drugs: Benzodiazepines
757
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
757
Opioid Analgesics: Synthetic and Semisynthetic Opioids
906
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
906
Anxiolytic Drugs: Benzodiazepines and Buspirone
2.3K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.3K
Opioid Analgesics: Morphine and Other Natural Cogeners
841
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
841
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K


